Literature DB >> 19609494

[Atypical cystic fibrosis. First diagnosed by chronic rhinosinusitis].

J G Mainz1, S Dornaus, C Dopfer, J F Beck, A Müller.   

Abstract

We present the case of a 44-year-old wrestler suffering from persistent bronchitis and chronic rhinosinusitis which had been refractory to therapy. The patient underwent extensive diagnostic examinations throughout the disease. Recently, at the age of 42 years otorhinological controls led to presentation at a cystic fibrosis (CF) centre where CF with the genotype Fdel508/3849+10 kb C-->T was diagnosed despite borderline sweat tests. Atypical CF should be considered in chronic persistent rhinosinusitis even in patients with borderline sweat tests.

Entities:  

Mesh:

Year:  2009        PMID: 19609494     DOI: 10.1007/s00106-008-1865-0

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  12 in total

Review 1.  Standards of care for patients with cystic fibrosis: a European consensus.

Authors:  Eitan Kerem; Steven Conway; Stuart Elborn; Harry Heijerman
Journal:  J Cyst Fibros       Date:  2005-03       Impact factor: 5.482

2.  European cystic fibrosis society consensus on standards--a roadmap to "best care".

Authors:  J M Littlewood
Journal:  J Cyst Fibros       Date:  2005-01-25       Impact factor: 5.482

Review 3.  Atypical CF and CF related diseases.

Authors:  Eitan Kerem
Journal:  Paediatr Respir Rev       Date:  2006-06-05       Impact factor: 2.726

Review 4.  Sinonasal disease in cystic fibrosis: clinical characteristics, diagnosis, and management.

Authors:  C Gysin; G A Alothman; B C Papsin
Journal:  Pediatr Pulmonol       Date:  2000-12

5.  The CFTR 3849+10kbC->T and 2789+5G->A alleles are associated with a mild CF phenotype.

Authors:  I Duguépéroux; M De Braekeleer
Journal:  Eur Respir J       Date:  2005-03       Impact factor: 16.671

6.  [Sweat testing practices in German cystic fibrosis centres].

Authors:  L Naehrlich
Journal:  Klin Padiatr       Date:  2007 Mar-Apr       Impact factor: 1.349

7.  Nasal potential difference measurements in patients with atypical cystic fibrosis.

Authors:  M Wilschanski; H Famini; N Strauss-Liviatan; J Rivlin; H Blau; H Bibi; L Bentur; Y Yahav; H Springer; M R Kramer; A Klar; A Ilani; B Kerem; E Kerem
Journal:  Eur Respir J       Date:  2001-06       Impact factor: 16.671

8.  Cystic fibrosis in 65- and 67-year-old siblings. Clinical feature and nasal potential difference measurement in patients with genotypes F508del and 2789+5G-->A.

Authors:  J Mainz; U Hammer; C Rokahr; A Hubler; F Zintl; M Ballmann
Journal:  Respiration       Date:  2006-06-06       Impact factor: 3.580

9.  Improved survival among young patients with cystic fibrosis.

Authors:  Michal Kulich; Margaret Rosenfeld; Christopher H Goss; Robert Wilmott
Journal:  J Pediatr       Date:  2003-06       Impact factor: 4.406

10.  Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study.

Authors:  R Mahadeva; K Webb; R C Westerbeek; N R Carroll; M E Dodd; D Bilton; D A Lomas
Journal:  BMJ       Date:  1998-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.